LucidScope
AI is already answering questions about your brand. LucidScope shows you what it’s saying, and why.
LucidScope evaluates how leading AI systems respond to real-world questions about your company, products, indications, and competitors.
It maps visibility and positioning in AI-generated answers, traces the sources shaping those answers, and highlights gaps where evidence is missing, outdated, or misrepresented.
What you can do with LucidScope:
-
Perception Mapping: Compare how AI positions your brand versus key competitors.
- See how AI frames your brand versus competitors, by theme and attribute.
-
Answers Mapping: See how models answer the same stakeholder questions, and where they diverge.
- View side-by-side model answers to your key questions, with differences highlighted.
-
Source Tracing: Identify which websites and documents are shaping AI answers, and where to intervene.
- Understand which domains and documents drive the answers, and what’s missing.
-
Launch and campaign monitoring: Track changes over time across models, markets, and topics.
- Monitor shifts in positioning, key claims, and cited sources (you vs competitors).
LucidScope is part of LucidQuest’s intelligence stack, complementing our primary research, conference coverage, and wargaming capabilities.
Combined with NexusBrain (nexusbrain.io), LucidScope insights can be mapped alongside your team’s own field observations to give a complete picture of how AI is shaping your brand’s perception.
Want to see what AI is saying about your brand? Request an AI Answer Audit.
You’ll receive a short report covering Perception, Answers, Source Tracing, and Zero-click gaps.
Already evaluating tools? Test LucidScope.
Questions or feedback? Email us anytime.
October 14, 2026
Women’s Health Strategic Roundup: Earlier Intervention | Sep 08 – Oct 13, 2026
October 13, 2026
AI in Healthcare and Digital Health Strategic Roundup: Clinical Adoption | Sep 12 – Oct 12, 2026
October 10, 2026
ECNP 2026 Preview: Emerging Psychiatric Therapies and Competitive Trends
October 9, 2026
HFSA 2026 Preview: Key Heart Failure Treatment Trends And Pipeline
October 9, 2026
Respiratory Strategic Roundup: Earlier Intervention | Sep 4–Oct 7, 2026
October 7, 2026
Cell and Gene Therapy Strategic Roundup | Sep 1 – Oct 6, 2026
October 7, 2026
Strategy Wargaming: What FDA’s Volixibat Signal Means for Ipsen
October 6, 2026
Obesity Strategic Roundup: Beyond GLP-1 Efficacy | Sep 1 – Oct 4 , 2026
October 6, 2026
CPHI 2026 Preview: Key Pharma Industry Trends to Watch
October 1, 2026
EURETINA 2026 Preview: Key Retinal Therapy Trends and Competitive Developments
September 30, 2026